The effects of baroreceptor stimulation on central respiratory drive: a review.
Simon McMullan, Paul M Pilowsky
https://pubmed.ncbi.nlm.nih.gov/20674807/Actively Recruiting
Led by University of Louisville · Updated on 2026-04-28
40
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating if non-invasive spinal cord stimulation can improve blood pressure control in people with chronic spinal cord injury SCI. This study focuses on understanding how stimulating specific sites on the spinal cord may help regulate blood pressure and affect enzymes involved in this process. The aim is to strengthen neurohormonal pathways to restore cardiovascular stability, reduce episodes of low or high blood pressure, and improve quality of life for individuals with SCI at or above the T1 neurological level and at least one year post-injury. Participants will receive spinal cord stimulation using up to six pairs of self-adhesive electrodes placed on the skin over the spinal cord and other body areas for stimulation. The study includes three intervention groups targeting different spinal cord levels thoracolumbar T10 to L1, lumbosacral L1 to S1, and thoracic T1 to T9 for respiratory function. Stimulation will be delivered 4 to 5 days per week for one hour per session, totaling eighty sessions over 16 to 20 weeks. Intensity and frequency will be adjusted individually, up to 200 mA and 100 Hz. Participants will undergo assessments before intervention, during various intervention points, post-intervention, and at 8- and 16-week follow-ups. Tests include measuring baroreflex sensitivity, kidney artery blood flow, and blood enzyme levels related to blood pressure regulation. Additional blood tests and monitoring for orthostatic hypotension will be performed. The study will track changes in cardiovascular stability and biochemical markers to understand the effects of spinal cord stimulation on blood pressure control in SCI.
CONDITIONS
Non-invasive Spinal Cord Stimulation and Blood Pressure Regulation After Spinal Cord Injury
A
Andrea M Willhite
K
Kristin Benton
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Louisville
Lead Sponsor
Kentucky Spinal Cord and Head Injury Research Board
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Cardiovascular Spinal Cord Transcutaneous Stimulation Montage 1 | Cardiovascular Spinal Cord Transcutaneous Stimulation Montage 2 | Respiratory Spinal Cord Transcutaneous Stimulation |
|---|---|---|---|
| What it is | Non-invasive transcutaneous spinal cord stimulation using a specific montage (CV-scTS 1) intended to modulate blood pressure in people with chronic motor-complete spinal cord injury. | Non-invasive transcutaneous spinal cord stimulation using a different montage or parameter set (CV-scTS 2), targeting cardiovascular regulation in spinal cord injury. | Non-invasive transcutaneous spinal cord stimulation applied with a respiratory-focused electrode configuration (Resp-scTS), studied for effects on blood pressure and autonomic symptoms. |
| Role in trial | Active comparator arm intended to assess cardiovascular effects of a specific scTS montage. | Active comparator arm to evaluate a different montage’s impact on blood pressure and autonomic symptoms. | Active comparator arm studies stimulation optimized for respiratory effects and its impact on blood pressure regulation. |
| Primary use | To assess whether this montage of spinal cord transcutaneous stimulation can improve cardiovascular regulation and reduce orthostatic hypotension in adults with chronic spinal cord injury. | To determine if a different montage or stimulation parameter set improves autonomic cardiovascular responses and mitigates hypotension. | To evaluate whether stimulation optimized for respiratory function also benefits blood pressure regulation and autonomic symptoms. |
| How it is given or performed | Stimulation is delivered through adhesive electrodes placed on the skin over the spinal cord and body, using a Biostim/Neostim device, with configuration specific to CV-scTS 1 parameters. | Stimulation uses a distinct montage and set of parameters but follows the same non-invasive electrode application over the spinal cord and reference body locations. | Electrodes are placed to optimize stimulation for respiratory muscle activation, but applications remain non-invasive with surface electrode configurations. |
| Evidence status | High-quality published evidence for this specific scTS montage is limited; most studies to date have focused on lumbosacral epidural stimulation. Transcutaneous approaches are being actively investigated. | No direct published studies exist for this montage and parameter set. Related device-based approaches are under study for autonomic dysfunction. | Published evidence is limited for respiratory-focused scTS montages. Respiratory training has shown some benefit for blood pressure regulation after SCI, but this exact stimulation method is investigational. |
| Important limitations | Limited clinical trial data for non-invasive scTS montages. Effects on cardiovascular regulation and safety require confirmation in further studies. | No specific published evidence for this exact montage and parameter combination. Findings may not generalize beyond the trial population or protocol. | Respiratory-optimized stimulation is investigational for both respiratory and cardiovascular outcomes in SCI, and its utility for blood pressure regulation outside the trial is undetermined. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 16 to 20 weeks
Participants receive transcutaneous spinal cord stimulation targeted for blood pressure regulation. The stimulation is delivered 4 to 5 days per week for one hour each day, over a period of 16 to 20 weeks, with sessions designed to strengthen neurohormonal pathways controlling blood pressure.
80 sessions delivered 4 to 5 days per week
Duration - 16 weeks
Participants return for follow-up visits to assess cardiovascular stability and blood pressure regulation improvements after treatment completion.
2 visits (at 8 weeks and 16 weeks after treatment)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Simon McMullan, Paul M Pilowsky
https://pubmed.ncbi.nlm.nih.gov/20674807/Michèle Hubli, Andrei V Krassioukov
https://pubmed.ncbi.nlm.nih.gov/24175653/Jill M Wecht, Noam Y Harel, James Guest...
https://pubmed.ncbi.nlm.nih.gov/32906175/Horacio Kaufmann, Richard Malamut, Lucy Norcliffe-Kaufmann...
https://pubmed.ncbi.nlm.nih.gov/22045363/Lynne C Weaver, Jennifer C Fleming, Christopher J Mathias...
https://pubmed.ncbi.nlm.nih.gov/23098715/M Itzkovich, I Gelernter, F Biering-Sorensen...
https://pubmed.ncbi.nlm.nih.gov/17852230/M N Ozer, S R Shannon
https://pubmed.ncbi.nlm.nih.gov/1898695/John W Osborn, Roman Tyshynsky, Lucy Vulchanova
https://pubmed.ncbi.nlm.nih.gov/33566672/Sevda C Aslan, Bonnie E Legg Ditterline, Michael C Park...
https://pubmed.ncbi.nlm.nih.gov/29867586/Edward J Johns, Ulla C Kopp, Gerald F DiBona
https://pubmed.ncbi.nlm.nih.gov/23737201/University of Louisville
Lead Sponsor
Kentucky Spinal Cord and Head Injury Research Board
Collaborating Sponsor